Augustine Therapeutics will be participating in the 2024 Peripheral Nerve Society (PNS) Annual Meeting at the Palais des Congrès de Montréal, Canada, on 22-25 June 2024.

The event is the largest international research conference across specialties in peripheral neuropathy. It is a great opportunity to connect with globally acknowledged researchers, clinicians, and investigators in the field.

Our Head of Early Clinical Development, Cédric Szyndralewiez, MSc. will be attending the 3-day conference and be available for 1-1 meetings to share our progress towards a new therapeutic approach selectively targeting HDAC6 inhibition for the potential treatment of inherited and hereditary neuropathies such as Chemotherapy-Induced Neuropathy and Charcot-Marie-Tooth disease.

For more information on the event: Click here